2001
DOI: 10.1038/sj.gt.3301499
|View full text |Cite
|
Sign up to set email alerts
|

Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiation

Abstract: One of the major problems with gene therapy today is

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
68
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 96 publications
(68 citation statements)
references
References 27 publications
0
68
0
Order By: Relevance
“…34 Other types of bacteria are currently being developed as anticancer agents. [6][7][8][9][10]35 In these strategies, spores of anaerobic bacteria are injected and selectively grow within the necrotic regions of tumours where they find a niche to grow. For example, C. novyi has shown some dramatic antitumour effects in combination with conventional chemotherapeutic drugs 35 and Salmonella are capable of targeting, colonizing and eliciting growth suppression of tumours in mice.…”
Section: Invasive E Coli As a Therapeutic Delivery Vector Rj Critchlmentioning
confidence: 99%
See 1 more Smart Citation
“…34 Other types of bacteria are currently being developed as anticancer agents. [6][7][8][9][10]35 In these strategies, spores of anaerobic bacteria are injected and selectively grow within the necrotic regions of tumours where they find a niche to grow. For example, C. novyi has shown some dramatic antitumour effects in combination with conventional chemotherapeutic drugs 35 and Salmonella are capable of targeting, colonizing and eliciting growth suppression of tumours in mice.…”
Section: Invasive E Coli As a Therapeutic Delivery Vector Rj Critchlmentioning
confidence: 99%
“…More recently, this concept has been re-evaluated using attenuated strains of Salmonella 6,7 and Clostridium. [8][9][10] A genetically attenuated strain of Salmonella (VNP20009) 7 was recently used in a clinical trial. 11 VNP20009 demonstrated marked toxicity when injected above 3 Â 10 8 CFU/m 2 .…”
Section: Introductionmentioning
confidence: 99%
“…In this approach, targeting bacteria are engineered to produce enzymes that can activate prodrugs within the tumor (9,29). Another possibility is to place the genes of prodrug-activating enzymes under the control of radiationinducible promoters to provide spatial and temporal control, thus enabling selective killing of tumor cells while sparing normal cells (28,30). So what are the potential problems with bacteriolytic therapy?…”
Section: Ironically a Tumor's Metabolically Compromised Microenvironmentioning
confidence: 99%
“…crease the sensitivity of tumors to radiation therapy and͞or evoke a host immune response (28). Another approach is bacteria-directed enzyme prodrug therapy (BDEP T), a variation of antibodydirected enzyme prodrug therapy (ADEPT).…”
Section: Ironically a Tumor's Metabolically Compromised Microenvironmentioning
confidence: 99%
“…Precise triggering of expression can boost drug concentration within tumors while minimizing harmful side effects (6). Salmonella can be engineered to induce protein expression in response to molecular triggers, radiation, or hypoxia (6,11,(13)(14)(15)(16)(17)(18). Molecular triggers are limited because small molecules cannot diffuse deep into tissue (19)(20)(21).…”
mentioning
confidence: 99%